DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ducreux M. et al.
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differenziated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial.
Eur J Cancer 2014;
50: 3098-3106
We do not assume any responsibility for the contents of the web pages of other providers.